Two cases pending at the EU Court of Justice (CJEU) address, respectively, questions on the licensing of standard essential patents (SEPs), and the availability of interim measures in litigation. With the hearings expected later this year, IPWatchdog looks at the key issues raised. It is relatively rare for patent cases to come before the CJEU, as there are no EU Directives or Regulations directly governing patents. However, the Court does hear patent cases when they also involve other aspects of EU law, such as Article 102 TFEU, concerning abuse of a dominant position; the Enforcement Directive; and the Biotechnology Directive. In the past few months, the German courts have referred questions in two important patent cases.
Recent Posts
- Novartis’ Entresto Patent Claims Revived by CAFC
- INTA Urges EUIPO Grand Board to Confirm Human Face Marks are Not Excluded from Trademark Registration
- New USPTO Fee Rule for Continuing Applications: Key Changes and Strategic Considerations for Applicants
- AI and the Level of Ordinary Skill: Why Patent Law Must (and Can) Adapt to AI-Augmented Invention
- Federal Circuit Upholds PTAB Win for Patent to Detect Genetic Disorders